Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
In Brief

Kevin Cullen to retire as director of UMGCCC

January 13, 2023
Vol.49 No.02
NIH, NCI budgets up by more than 5% in FY23; FDA gets more robust accelerated approval authority
Capitol Hill

NIH, NCI budgets up by more than 5% in FY23; FDA gets more robust accelerated approval authority

January 06, 2023
Vol.49 No.01
By Matthew Bin Han Ong
NCI oral history: J. Palmer Saunders on being tasked to investigate NCI’s Chemotherapy Program
FreeIn the Archives

NCI oral history: J. Palmer Saunders on being tasked to investigate NCI’s Chemotherapy Program

January 06, 2023
Vol.49 No.01
NCI’s Cancer Prevention-Interception Targeted Agent Discovery (CAP-IT) Program, a milestone in cancer prevention research
FreeGuest Editorial

NCI’s Cancer Prevention-Interception Targeted Agent Discovery (CAP-IT) Program, a milestone in cancer prevention research

December 21, 2022
Vol.48 No.46
By Margie Clapper
Top 25 stories of 2022
EditorialFree

Top 25 stories of 2022

December 21, 2022
Vol.48 No.46
By Alexandria Carolan and Katie Goldberg
NCI BSA approves eight new, reissue concepts at BSA/NCAB joint meeting

NCI BSA approves eight new, reissue concepts at BSA/NCAB joint meeting

December 16, 2022
Vol.48 No.45
By Jacquelyn Cobb
The National Cancer Act 20 years later: impact as seen by its architects in 1991
In the Archives

The National Cancer Act 20 years later: impact as seen by its architects in 1991

December 16, 2022
Vol.48 No.45
NCI Director Monica Bertagnolli has breast cancer
Conversation with The Cancer LetterFree

NCI Director Monica Bertagnolli has breast cancer
“I have more motivation to get up every morning to keep doing what I do”

December 14, 2022
Vol.48 No.45
By Paul Goldberg and Matthew Bin Han Ong
NCI’s Bertagnolli & ARPA-H’s Wegrzyn have been plotting to make the most of their strengths and differences

NCI’s Bertagnolli & ARPA-H’s Wegrzyn have been plotting to make the most of their strengths and differences

December 09, 2022
Vol.48 No.44
By Matthew Bin Han Ong
PAMN: How cancer centers develop ways to communicate the value of research
Guest Editorial

PAMN: How cancer centers develop ways to communicate the value of research

December 09, 2022
Vol.48 No.44
By Heidi Findlay

Posts navigation

Previous1…272829…39Next

Trending Stories

  • OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
  • What NHS-Galleri taught us—and what it didn’t
  • The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
  • Is psilocybin heading to a cancer clinic near you?
    Reversing Nixon-era taboo, Trump orders FDA to fast-track psychedelics and ARPA-H to fund research
  • Ian Krop named section chief of Medical Oncology and Hematology and deputy director for Clinical Affairs at Yale
  • FDA clears a way for dramatic reduction in animal toxicology studies in cancer

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account